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Objective: The objective of this study is to assess the impact of surgery on quality of life (QOL) in patients who underwent
thoracoabdominal aortic aneurysm (TAAA) repair.
Methods: This is a prospective single center cohort study using two quality of life questionnaires administered before
surgery, at 6 months, and 1 year after surgery. The Illness Intrusiveness Rating Scale (IIRS) is a tool that on a 7-point
Likert scale assesses the impact of disease on each of 13 domains of quality of life. The Karnofsky Activity Scale (KAS) uses
a single rating to assess the impact on overall quality of life. At each visit, participants completed the IIRS and KAS.
Healthy, nonaneurysmal individuals also completed the IIRS to form a control group.
Results: From 1998 to 2006, 297 patients underwent thoracoabdominal aneurysm repair at a tertiary care hospital.
Quality of life was measured on 80 patients in total. Preoperative data was available in 45 patients (7 completed the IIRS
and 3 the KAS only, and 35 both); 6-month postoperative data in 25 (1 completed the KAS only, and 24 both); and
1-year data postoperative in 35 (4 completed the IIRS and 2 the KAS only, and 29 both). Internal consistency was
established for IIRS (Cronbach’s alpha 0.85) and KAS (0.81). The mean preoperative IIRS score was 32.10 (SD 17.91).
After surgery, there was no change at the 6-month and 1-year postoperative intervals: at 6 months, the mean IIRS score
was 33.17 (SD 17.66) and at 1 year the mean was 28.09 (SD 13.61). Total IIRS in nonaneurysmal controls was 13.5 (SD
0.7). The mean preoperative Karnofsky Activity Scale score was 80.0 (SD 15.07), which corresponds to an ability to
perform normal activity with effort and some signs or symptoms of disease. After surgery, there was no change as patients
reported a 6-month mean score of 79.60 (SD 21.89), and a 1-year postoperative mean score of 86.94 (SD 13.94).
Conclusions: Quality of life for patients undergoing TAAA repair who survive to attend follow-up in an ambulatory
setting can be measured using reliable and valid instruments. Preoperatively, QOL is poor compared with healthy
controls. After surgery, at 6- and 12-month follow-up, QOL seems to return to the preoperative levels. Further research
is necessary to address responsiveness and sensitivity of QOL measuring tools. ( J Vasc Surg 2009;50:251-5.)In population-based studies, the prevalence of thoraco-
abdominal aortic aneurysms (TAAA)1 and thoracic aortic
aneurysms2 is 5.9 and 10.4 per 100,000 person years in the
white population. This prevalence increases with age and is
greater in men than in women. The largest single-center
series indicates that surgery for TAAA represents 10% of all
surgeries for aneurysms of the aorta.3
The rationale for surgical intervention in thoracoab-
dominal aneurysms is the prevention of spontaneous rup-
ture and death. Without treatment, the risk of rupture and
5-year survival in thoracic aortic aneurysms (aneurysm
greater than 5 cm or twice the size of the normal proximal
or distal aorta) is estimated to be 47% to 74% and 21% (95%
CI 15-32), respectively, in cohort studies from tertiary care
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tic aneurysms have documented a 5-year survival rate of
39% (95% CI 46% to 73%) and 4-year risk of rupture of 32%
(95% CI 11% to 41%).5 Crawford evaluated 94 patients
who did not undergo thoracoabdominal aortic aneurysm
repair either because of associated disease, age, small size of
aneurysm, procedure refusal, and found by Kaplan-Meyer
curve analysis that the 2-year survival rate was only 24%.6
Half of the deaths in this series were due to rupture.
The incidence of postoperative complications after
TAAA repair is high, including up to 32% incidence of
respiratory insufficiency, 21% incidence of renal dysfunc-
tion, 14% incidence of paraplegia/paraparesis, and 12%
incidence of pulmonary infection.7 Rupture is the first sign
of the disease in 10% to 20% of patients.8 TAAAs are largely
asymptomatic, however, a greater number of patients than
in the past are aware of this medical condition as a conse-
quence of ageing and increased ascertainment. We hypoth-
esize that these patients who are made aware of their
condition may experience increased fear and anxiety, which
worsens quality of life, and that the latter may be worsened
in those patients in whom surgery is performed.
We believed that an instrument to describe the burden
of illness and to quantify the effect of the interventions on
quality of life is needed in order to help physicians and
patients to communicate realistically on surgical outcomes.
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of thoracoabdominal aortic aneurysms and surgery on the
quality of life of these patients.
MATERIAL AND METHODS
Participants. This is a prospective cohort study of
elective patients with TAAA being considered for surgical
intervention by a single surgeon at a tertiary care center
between 1998 and 2006. All patients were enrolled before
endovascular repair of TAAA was made available in a rou-
tine fashion at our institution.
Participants in the quality of life study (study group)
were compared with all other patients undergoing a TAAA
repair who did not participate in the study (TAAA control
group). In addition, participants randomly selected from
among office assistants, and individuals from physicians’
offices older than 15 years of age and who were not affected
by aneurysmal disease provided a nonaneurysmal control
group. The study received institutional ethic review board
approval.
Instrument. In this study population, two quality of
life instruments were used, in order to strengthen their
validity (convergent validity). The first is the Illness Intru-
siveness Rating Scale (IIRS), which uses a 7-point Likert
scale to assess the impact of disease on each of 13 domains
of quality of life: health, diet, work, active and passive
recreation, financial situation, relationship with spouse/
significant other, sex life, family and other social relations,
self expression/self improvement, religious expression, and
community/civic involvement. For each domain of the
IIRS, a response of 7 represents “most intrusive” or “more
severe” problems while a response of 1 represents “mini-
mal” or “no problems”. Scores on this scale decrease with
improvement in quality of life.
We chose to investigate the properties of the Illness
Intrusiveness Ratings Scale (IIRS) because the concept of
intrusiveness seemed to capture the condition’s disruptive
effects on many aspects of life described by patients. Previ-
ous research has supported the construct validity of the
scale. The IIRS has been shown to have internal consistency
(Cronbach’s alpha of 0.80 to 0.88)9-11 and test-retest
reliability (K of 0.79 to 0.85)10,12-15 in assessing quality of
life in chronic and life threatening conditions. It is a short,
self-administered scale of 13 items. The brevity of the scale
is an important factor considering the applicability of the
instrument to clinical practice.
The second instrument is the Karnofsky Activity Scale
(KAS), which uses a single rating from 0-100 to assess the
impact on overall quality of life, ranging from “0: dead” to
“100: normal, no complaints, no evidence of distress”.
Scores increase with improvements in quality of life. The
Karnofsky Activity Scale has been used to assess the severity
of impact of abdominal aortic aneurysms on quality of
life.16 It has additionally been shown to be reliable and valid
in cancer patients, with inter-rater reliability (K .97) and
validity (r 0.30).17 Its validity and reliability as a universal
indicator of quality of life has been demonstrated in previ-
ous research.18-20We believed that the use of a generic instrument (KAS)
in combination with one that is disease-specific (IIRS) may
provide the most comprehensive data.21
All patients completed the self-administered question-
naire before surgery, and at two routine postoperative
follow-up periods at 6-month and 1-year. For the purposes
of this study, if participants completed more than one scale
following the 1-year interval, the score with the earliest date
was selected in order to provide comparable results to those
patients whose follow-up was shorter. Patients requiring
urgent or emergent TAAA repair were excluded from anal-
ysis. In a subset of 10 patients, the quality of life scale was
administered twice before surgery at a 4-week interval. In
addition, the IIRS was administered to the nonaneurysmal
control group.
Surgical technique. We have previously described our
center’s approach to open thoracoabdominal aneurysm
repair in detail, which included a protocol-based strategy.
Mortality and morbidity of the surgery have been reported
elsewhere.22-25
Statistical analysis. All data was tabulated in an elec-
tronic database using Microsoft Access. Statistical analysis
was undertaken using SPSS (Version 12). Fisher exact test
was used for categorical variables, and unpaired two-tailed t
test for continuous. We used analysis of variance for con-
tinuous variables to compare changes in pre- and postop-
erative scores. A P value .05 was considered significant.
Cronbach’s alpha was calculated to test the internal consis-
tency. Analysis of variance components and intraclass cor-
relation (ICC) were used to calculate test-retest reliability.
RESULTS
From 1998 to 2006, there were 297 TAAA repairs
performed at our tertiary care center, and pre- and postop-
erative QOL assessment was performed on 80 patients
(study group) who were administered both scales. None of
the patients participating in this study suffered paraplegia or
had renal failure requiring permanent dialysis. Preopera-
tively, 35 patients completed both the IIRS and the KAS
and seven patients only the IIRS and three only the KAS; at
6 months 24 completed both scales and one only the KAS;
at 1 year 29 completed both scales, four only the IIRS and
two only the KAS (Fig 1). The total IIRS score for the
healthy, nonaneurysmal control group was 13.5  0.7,
which was significantly different from that observed in
patients with TAAA at any time point, before or after
surgery (Table I). Quality of life data on the KAS scale was
available for 38 patients before surgery, 25 at 6 months and
32 at 1 year after surgery. Demographic variables associated
with surgical outcome for participants in the study and in
the TAAA control group are described in Table II. The
study group was younger (P  .03), had a greater number
of more complex group II TAAA and had a higher serum
albumin level (P .001). There appears to be fewer urgent
cases in the study group and better renal function, but this
difference did not achieve statistical significance (P  .08).
In-hospital mortality occurred in five patients who com-
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tients in the cohort (P  .08).
Internal consistency of the IIRS and the KAS was
high, Cronbach’s alpha 0.85 and 0.81, respectively.
Test-retest reliability was also high, ICC coefficient 0.89.
Mean KAS and IIRS scores for each time interval are
reported in Table III and the results of the individual
items for the IIRS are reported in Table IV. There was
not a statistical difference in the total score of the IIRS
before and after surgery at 6 and 12 months. The results
of the QOL as measured by the KAS appeared to improve
over time, but the difference did not achieve statistical
significance (P  .07).
DISCUSSION
We use the IIRS and the KAS to provide a composite
global assessment of quality of life because previous authors
have demonstrated that the IIRS is reliable and valid for
Fig. Flow chart of participants.
Table I. IIRS scores for the healthy, nonaneurysmal
control group
Controls
(N 11) mean  SD
Health 1  0
Diet 1.1  0.2
Work 1.1  0.2
Active recreation 1.3  0.5
Passive recreation 1  0
Financial situation 1  0
Relationship: spouse 1  0
Sex life 1  0
Family relations 1  0
Social relations 1  0
Self expression 1  0
Religious expression 1  0
Community 1  0
Total IIRS score 13.5  0.7
IIRS, Illness Intrusiveness Rating Scale.chronic and life threatening conditions and KAS16 has alsobeen used to assess quality of life in aortic aneurysms.26 We
have shown that participants with TAAA before surgery
have low KAS scores (mean 80%), and that they have higher
IIRS scores (mean 32) than healthy nonaneurysmal con-
trols (mean of 13.5), and more in keeping with the results
obtained in transplant patients (bone marrow [37.5, 95%
CI, 32.3-42.8], lung [30.4, 95% CI, 25.8-35.1] and liver
transplants [32.2, 95% CI, 29.2-35.3]) or in patients with
severe chronic conditions such rheumatoid arthritis (38,
95% CI, 34-44).14,27
It is difficult to explain how a seemingly asymptomatic
condition affects quality of life in such a profound manner.
Perhaps the associated comorbidities and the anxiety
caused by hosting the disease may in part be responsible for
these results. A study of 1509 patients with TAAA showed
that comorbidities are prevalent in this population and
include chronic lung disease in 40% (95% CI 37.5-42.4),
atherosclerotic heart disease in 31% (95% CI 28.8-33.5),
cerebrovascular disease in 15% (95% CI 13.4-17.1), and
renal insufficiency in 13% (95% CI 12.2-15.7).3 All of these
may profoundly affect quality of life.
Olsson et al, using eight dimensions of the SF-36
showed that (except for bodily pain) the quality-of-life after
thoracic aortic surgery was acceptable, although worse than
in the normal population.28 Eide et al, using a short form of
the SF-36 showed that in thoracoabdominal aortic aneu-
Table II. Demographics in participants for the study
group and TAAA control
Study group
TAAA control
group P
N 80 219
Male sex (%) 66 58.9 .73
Age, mean (SD) 66.2 (11.0) 69.3 (10.7) .03
Aneurysm size in cm,
mean (SD) 6.42 (1.2) 6.59 (1.5) .37
TAAA type, number (%)
Ia 6 (8) 8 (4.3) .21
Ib 7 (9) 22 (11.8) .83
II 28 (35) 36 (19.3) .001
III 7 (10.1) 34 (18.3) .13
IV 21 (26) 83 (44.62) .06
V 0 (0.0) 3 (1.61) .57
Type of surgery,
number %
Urgent 1 (1.3) 15 (6.8) .08
Emergency 1 (1.3) 6 (2.7) .70
FEV1, L , mean (SD) 2.3 (0.8) 2.2 (0.6) .25
FEV1/FVC, %
predicted, mean
(SD) 61.7 (21.4) 70.2 (18.7) .001
Grade 1 ventricle (%) 100 100 1.00
Serum creatinine,
mol/L 113.7 (55.8) 128.2 (65.7) .08
Serum albumin, g/L 41.5 (4.7) 35.7 (7.1) .0001
Smokers (past or
present), % 66 53.4 .08
FEV1, Forced expiratory volume 1st second; FVC, forced volume capacity;
L, liter; TAAA, thoracoabdominal aortic aneurysms.rysm surgery, most patients reported an acceptable health
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of quality of life measures at 6 and 12 months were un-
changed compared with those recorded preoperatively,
they were still indicative of significant impairment. This
suggests that after appropriate recovery, the quality of life
of these patients returns to their preoperative status. We
cannot, however, exclude with certainty that deterioration
does not occur. A ceiling effect and unresponsiveness of the
measuring scale to change might be responsible for our
findings.30
Zierer et al have shown that QOL in patients under-
going TAAA repair is worse than that in those undergo-
ing ascending or descending aneurysms repair, and that
this effect is independent of age.31 Long-term quality of
life at 5 years of patients receiving thoracic aortic aneu-
rysm repair seems to be reduced compared with con-
trols.32 Endovascular aortic aneurysms repair (EVAR)
offers promises of reducing mortality and improv-
ing quality of life. Interestingly, in Dick’s study, patients
undergoing thoracic endovascular aneurysms repair
(TEVAR) did not score higher in overall quality of life
compared with those who received open surgery despite
all advantages of minimized access trauma.32 Similarly,
anxiety and depression scores were not reduced by
TEVAR, possibly reflecting a certain caution against the
new technology.
The strength of our work is based on the use of two
different scales to assess quality of life, the simplicity with
Table III. KAS and IIRS scores for each time interval
Preoperative mean
IIRS score, mean (SD) (N  42) 32.10 (17.91)
KAS score, mean (SD) (N  38) 80.00 (15.07)
IIRS, Illness Intrusiveness Rating Scale; KAS, Karnofsky Activity Scale.
Table IV. Categorical IIRS scores for each time interval
No Preoperative mean
Health 62 3.40 (2.53)
Diet 63 2.64 (2.14)
Work 63 2.98 (2.47)
Active recreation 63 3.77 (2.61)
Passive Recreation 63 1.66 (1.54)
Financial Situation 63 2.23 (1.94)
Relationship: Spouse 62 2.40 (2.19)
Sex life 62 3.00 (2.61)
Family relations 63 2.05 (1.87)
Social relations 63 2.31 (1.84)
Self expression 62 2.51 (1.97)
Religious Expression 61 1.43 (1.09)
Community 61 2.14 (1.89)
IIRS, Illness Intrusiveness Rating Scale.which these scales may be used in clinical practice to aid indecisionmaking regarding indications for surgery, the large
sample size, and length of follow-up.
We suggest that the results obtained in the cohort of
patients in whom quality of life was studied are generalizable
to the entire cohort of patients undergoing TAAA repair.
Although there is likely an intrinsic selection bias (eg, differ-
ences in serum albumin and age were identified between the
study group and TAAA control group), which interferes with
the interpretation of QOL studies, an association with the
relationship between questionnaire participation and out-
comes cannot be ruled out. If this is indeed a real effect, then
it would certainly be a problem that may be generalized to all
studies using QOL as an outcome. This might lead to
discussing the appropriateness of insurers trying to add
QOL criteria to pay-for-performance and ratings outcomes
for operations such as these. In our study, the responders to
the QOL questionnaires appeared younger that the TAAA
control group. However, a study of thoracic aortic aneu-
rysms concluded that while the impact on physical aspect of
quality of life is greatest with TAAA repair, advanced age is
not predictive of impaired recovery compared to younger
patients.31
The inference that may be drawn by our work is
further limited by lack of randomization and selection
bias; the propensity for patients to exaggerate the sever-
ity of their condition to be eligible for surgery and
underplay symptoms following intervention; recall bias
as responses to the questionnaires may be affected by the
Postoperative mean
P6 mo P 12 mo
24) 33.17 (17.66) (N  33) 28.09 (13.61) .13
25) 79.60 (21.89) (N  31) 86.94 (13.94) .07
)
Postoperative mean (SD)
P6 mo 12 mo
3.66 (2.18) 3.09 (1.98) .42
2.46 (2.17) 1.51 (1.09) .07
2.88 (2.58) 1.97 (1.69) .06
4.00 (2.52) 3.20 (2.17) .17
1.75 (1.54) 1.74 (1.58) .94
2.58 (2.48) 2.06 (1.78) .36
2.29 (1.85) 1.88 (1.75) .29
2.71 (2.51) 2.44 (2.27) .45
1.83 (1.58) 1.64 (1.56) .39
2.58 (2.08) 2.15 (1.82) .45
2.75 (1.98) 2.55 (2.17) .78
1.58 (1.06) 1.64 (1.60) .65
2.08 (2.06) 2.42 (2.29) .63(N 
(N (SDpatients’ memories.
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Surgical repair is an effective treatment for TAAA with
acceptable results in tertiary centres with expertise in the
management of this condition. The quality of life as as-
sessed by the IIRS and KAS scales is poor before surgery,
but seems to return to the preoperative status after 6 to 12
months recovery. Further studies addressing responsive-
ness to change of QOL measuring scales and their sensitiv-
ity in this patient population are necessary to better define
the impact on quality of life of patients undergoing TAAA
repair.
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